Being born with one kidney is uncommon but far from rare. Best estimates put the birth prevalence of a solitary functioning kidney at roughly 1 in 500 to 1 in 1,000 newborns, and the most-cited registry figure for unilateral renal agenesis alone is about 1 in 2,000. The right kidney is missing more often than the left, and males are affected somewhat more often than females. In the United States, that translates to somewhere between 3,000 and 7,000 affected newborns each year — comparable in frequency to well-known birth conditions that every parent hears about.

The two routes to a solitary kidney

A baby can end up with one working kidney by two distinct developmental paths, and the difference matters clinically. The first is renal agenesis: the kidney never forms at all. The second is renal dysplasia severe enough that one kidney is a small, poorly functioning remnant, or the loss of a kidney in utero through vascular accident. Both are grouped as a solitary functioning kidney because the child lives with the same physiology — one working filtration unit from birth.

Why does agenesis happen? The kidney develops from two tissue populations that must meet and signal each other. A duct called the ureteric bud grows out of the embryonic duct and invades a mass of intermediate mesoderm called the metanephric mesenchyme. The bud tells the mesenchyme to form nephrons; the mesenchyme tells the bud to branch. If the bud fails to form or fails to reach the mesenchyme on one side, no kidney develops on that side. The same signaling failure often affects the ureter, which is why the remaining kidney's collecting system and bladder anatomy warrant close inspection.

Here is the detail most brief explainers skip: the metanephric mesenchyme on the affected side often persists as undifferentiated tissue rather than vanishing. That leftover tissue can occasionally give rise to other problems, and it explains why agenesis is not simply "one kidney removed." The developmental insult was a signaling failure affecting a whole region, not an isolated missing organ.

Timing matters too. Nephrogenesis — the actual construction of nephrons — is essentially complete by 34 to 36 weeks of gestation. A baby born with one kidney cannot grow new nephrons after birth. The kidney they have was built during a fixed window, which is why the single kidney often shows compensatory enlargement by the third trimester: it is working harder before birth, not after.

How often it actually happens

Prevalence figures depend heavily on how you count. Autopsy series and imaging studies produce different numbers than birth registries, and renal agenesis is frequently underdiagnosed because a child with one good kidney usually has no symptoms at all.

The most-cited estimate for unilateral renal agenesis is approximately 1 in 2,000 births, based on large registry analyses. Broader definitions of solitary functioning kidney — including a dysplastic or nonfunctioning remnant — push the figure toward 1 in 500 to 1 in 1,000. The kidney may be absent on either side; the right is missing somewhat more often than the left in most series.

Finding Approximate frequency What it counts
Unilateral renal agenesis ~1 in 2,000 births Kidney entirely absent
Solitary functioning kidney (broad) ~1 in 500 to 1 in 1,000 births Absent or nonfunctioning remnant
Bilateral renal agenesis ~1 in 3,000 to 1 in 5,000 births Both kidneys absent; usually fatal
Horseshoe kidney ~1 in 500 births Fused kidneys, two present
Duplex collecting system ~1 in 100 to 1 in 125 Extra collecting system, not missing tissue
Supernumerary kidney far rarer than 1 in 1,000 An extra third kidney

Notice the asymmetry in that table. Being born with an extra collecting system inside a kidney is common — around 1 percent of people. Being born with an extra whole kidney is exceptionally rare. The developmental machinery that builds kidneys is far more prone to partial duplication than to wholesale extra organ formation, which is why "one kidney" is a realistic concern and "three kidneys" is a case-report curiosity.

In absolute terms, with roughly 3.6 million US births per year, the broad estimate implies several thousand affected infants annually, while the narrow agenesis figure implies roughly 1,800. Both numbers are large enough that most pediatric nephrology practices see these children regularly.

When one kidney is not the whole story

Isolated solitary kidney is the common scenario, but agenesis frequently travels with other developmental anomalies. The same embryologic signaling that builds the kidney also builds the ureter, bladder, and parts of the reproductive tract, so a missing kidney raises the probability of a missing or malformed structure nearby.

The most important association is with the female reproductive tract. Girls with unilateral renal agenesis have an elevated risk of Müllerian anomalies — a missing or malformed uterus, a blocked vaginal canal, or a double uterus. A specific combination, sometimes called Herlyn-Werner-Wunderlich syndrome, pairs a blocked hemivagina with a same-side kidney anomaly and can present at puberty with severe pelvic pain. Boys can have same-side abnormalities of the vas deferens or epididymis. This is why a finding of agenesis on prenatal ultrasound usually prompts a careful look at the pelvis, not just the kidneys.

The other associations worth flagging are cardiovascular and skeletal. Renal agenesis appears with increased frequency in children who also have congenital heart defects or vertebral anomalies, and it is part of several named syndromes. VACTERL association — vertebral, anal, cardiac, tracheoesophageal, renal, and limb anomalies — is the pattern clinicians screen for, because finding one component raises the probability of the others.

A professional caveat: many of these associations come from referral-center series, where children with multiple anomalies are overrepresented. The risk for a child with an isolated single kidney and a normal ultrasound of everything else is much lower than the risk quoted in syndrome literature. Do not apply referral-center percentages to a healthy newborn with one kidney and no other findings.

There is also a genuinely counterintuitive point about the remaining kidney. Compensatory growth is not just hypertrophy of existing nephrons — the single kidney can show a marked increase in size, and in some children it hyperfilters from an early age. Glomerular hyperfiltration is the mechanism by which a single kidney can maintain normal total filtration, but sustained hyperfiltration is also the hypothesized pathway to long-term kidney injury. The same adaptation that protects filtration in childhood may carry a cost decades later. That trade-off is the reason long-term follow-up exists at all.

What people get wrong

Several widespread beliefs about single kidneys deserve correction.

First, many people assume a solitary kidney means automatic kidney disease. It does not. The large majority of people born with one kidney have normal kidney function and live normal lives, and most are never even diagnosed because no one images them. The elevated risk is statistical, not destiny.

Second, there is a persistent belief that the single kidney will simply "wear out" from overwork. That framing is too simple. Hyperfiltration is real, but the outcome depends on the starting kidney's quality, blood pressure, body weight, and whether the remaining kidney is truly normal. A well-formed single kidney in a person with normal blood pressure may function normally for a lifetime; a dysplastic remnant in a person with obesity and hypertension is a different situation entirely.

Third, people conflate being born with one kidney with having one kidney removed. A person who donates a kidney or loses one to surgery usually had two kidneys' worth of nephrons during development and then lost half. A person born with one kidney never built the second set. The nephron endowment differs, and nephron number at birth is itself a determinant of later kidney health — a lower endowment is associated with higher long-term risk of hypertension and kidney decline. The two situations are close but not identical.

Fourth, there is the myth that solitary kidney always comes from something the mother did. The evidence does not support blaming a specific prenatal exposure in most cases. Most cases are sporadic and unexplained. Certain maternal conditions and medications are associated with increased risk in epidemiologic studies, but association is not causation for any individual family, and the majority of cases have no identifiable cause.

Fifth, people assume a prenatal diagnosis is definitive. Ultrasound before 20 weeks can miss an absent kidney, and a small dysplastic remnant can be mistaken for a normal kidney or vice versa. Postnatal imaging is the confirmation step.

Practical steps and red flags

For parents and adults with a known solitary kidney, the practical plan is concrete and modest. None of it is exotic, but each step has a threshold or timing attached.

Confirm the diagnosis with postnatal imaging rather than relying on prenatal ultrasound alone. A kidney that appears absent at 20 weeks should be re-imaged after birth. Check blood pressure at every well-child visit and at least annually in adults. Hypertension is the single most modifiable risk factor for long-term kidney decline. Check urine for protein periodically. Protein in the urine is the earliest sign of glomerular stress from hyperfiltration and is treatable when caught early. Screen for associated anomalies. In girls, pelvic imaging is warranted to look for Müllerian abnormalities. In any child, a careful cardiac and spinal exam is part of the initial assessment. Avoid nephrotoxic exposures where possible, and tell every clinician about the single kidney before imaging studies involving contrast or before any medication known to stress the kidney. Maintain a healthy weight and treat diabetes and hypertension aggressively if they develop. Obesity increases the filtration load the single kidney must carry.

Red-flag findings that should prompt prompt evaluation rather than routine follow-up:

Blood pressure above the 95th percentile for age, sex, and height on repeated measurement. Any persistent protein on urine dipstick, especially in a child. A creatinine that is rising over successive measurements rather than stable. Blood in the urine, recurrent urinary tract infections, or unexplained flank pain. A single kidney that measures unusually small or shows scarring on imaging. Any new pubertal pelvic pain in a girl with known renal agenesis, which can signal a blocked reproductive tract.

The follow-up schedule itself is a reasonable place to reconcile thresholds. Different guidelines suggest different surveillance intervals — roughly annually for blood pressure and urine protein in children, with kidney function measured periodically and more often if any abnormality appears. The reconciliation is straightforward: annual blood pressure and urine checks for everyone; serum creatinine and imaging on a schedule determined by the remaining kidney's appearance and by any abnormal findings. If everything is normal, surveillance can be light. If anything is abnormal, it escalates.

What the numbers can and cannot tell you

The frequency figures carry real uncertainty. Prenatal ultrasound detects many cases, but not all, and the true population prevalence depends on how aggressively you image healthy children — which nobody does. Autopsy data, birth registries, and imaging series each have different denominators and different case definitions. The honest statement is a range: solitary functioning kidney affects somewhere around 1 in 500 to 1 in 1,000 births, with agenesis alone near 1 in 2,000.

The long-term risk figures carry even more uncertainty. Much of the outcome data comes from children followed in specialty clinics, who are not representative of the whole population. Studies with long follow-up show that a meaningful minority — not a majority — develop proteinuria, hypertension, or reduced kidney function over years to decades. But the exact proportion varies by definition of the solitary kidney, by age at last follow-up, and by how many of the children had an abnormal remaining kidney at baseline. Numbers quoted from specialty cohorts overstate risk for the typical healthy child with one normal kidney.

What is well established: a single kidney from birth is a common-enough variant that pediatric nephrologists see it routinely; it usually produces normal kidney function; and its main long-term risks — hypertension, proteinuria, and progressive decline — are the same risks that ordinary preventive care addresses. The practical takeaway is not fear. It is that a known single kidney turns generic health maintenance into targeted surveillance, and that surveillance is cheap, noninvasive, and effective when started early. The frequency estimates say this affects thousands of families a year in the US alone; the mechanism says the remaining kidney adapts; and the long-term data say that adaptation is usually successful but deserves watching rather than assuming.